Sinovac Biotech Ltd (SVA)
6.47
0.00 (0.00%)
USD |
NASDAQ |
Nov 13, 16:00
Sinovac Biotech Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
December 31, 2020 | 108.83M |
September 30, 2020 | 11.16M |
June 30, 2020 | -3.76M |
March 31, 2020 | -5.862M |
December 31, 2019 | 23.20M |
September 30, 2019 | 7.794M |
June 30, 2019 | 12.15M |
March 31, 2019 | 1.789M |
December 31, 2018 | -1.165M |
September 30, 2018 | 8.862M |
June 30, 2018 | 5.725M |
March 31, 2018 | 8.36M |
December 31, 2016 | 4.449M |
September 30, 2016 | 3.205M |
June 30, 2016 | -9.559M |
March 31, 2016 | 1.309M |
December 31, 2015 | 0.162M |
September 30, 2015 | -1.598M |
June 30, 2015 | 2.27M |
March 31, 2015 | -2.251M |
December 31, 2014 | 0.64M |
September 30, 2014 | 0.089M |
June 30, 2014 | -2.248M |
March 31, 2014 | 0.004M |
December 31, 2013 | 5.822M |
Date | Value |
---|---|
September 30, 2013 | 2.31M |
June 30, 2013 | 1.319M |
March 31, 2013 | -2.009M |
December 31, 2012 | -4.608M |
September 30, 2012 | -3.002M |
June 30, 2012 | -1.630M |
March 31, 2012 | -5.613M |
December 31, 2011 | 2.770M |
September 30, 2011 | -2.142M |
June 30, 2011 | 1.324M |
March 31, 2011 | -2.795M |
December 31, 2010 | -8.948M |
September 30, 2010 | -0.2976M |
June 30, 2010 | 1.045M |
March 31, 2010 | -0.3073M |
December 31, 2009 | 8.900M |
September 30, 2009 | 5.225M |
June 30, 2009 | 5.809M |
March 31, 2009 | 0.0247M |
December 31, 2008 | 2.374M |
September 30, 2008 | 0.7399M |
June 30, 2008 | 3.336M |
March 31, 2008 | 1.56M |
December 31, 2007 | 1.993M |
September 30, 2007 | 2.190M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-5.862M
Minimum
Mar 2020
108.83M
Maximum
Dec 2020
26.71M
Average
11.16M
Median
Sep 2020
Net Income (Quarterly) Benchmarks
CASI Pharmaceuticals Inc | -6.965M |
Zai Lab Ltd | -80.28M |
China SXT Pharmaceuticals Inc | -- |
Adagene Inc | -- |
LakeShore Biopharma Co Ltd | -14.51M |
Net Income (Quarterly) Related Metrics
Enterprise Value | -6.942B |
Earnings Yield | -20.25% |
Normalized Earnings Yield | -10.50 |